TrialBMJ (Clinical research ed.)2026

Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).

Manjula Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.